{"entity":{"type":"insider","cik":"0001250320","url":"/insider/0001250320","json_url":"/insider/0001250320.json","name":"PRENTKI RONALD J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":78,"n_filings":11,"first":"2004-04-21","last":"2008-08-06","span_basis":"filed_date"},"name_variants":[{"name":"PRENTKI RONALD J","source":"filing","n_filings":11,"first_seen":"2004-04-21","last_seen":"2008-08-06"}],"transactions":[{"id":2909120,"accession":"0001250320-08-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001250320-08-000004","line_url":"/filing/0001250320-08-000004","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"AP PHARMA INC /DE/","issuer_ticker":"APPA","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1860.0,"shares_display":"1,860","price_per_share":1.4235483870967742,"price_display":"1.42","price_state":"stated","total_value":2647.8,"total_display":"2,647.80","total_whole":"2,648","shares_owned_after":1860.0,"shares_owned_after_display":"1,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-01","filed_date":"2008-08-06","scope":"insider","n_lines":2},{"id":2909106,"accession":"0001250320-08-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001250320-08-000004","line_url":"/filing/0001250320-08-000004#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"AP PHARMA INC /DE/","issuer_ticker":"APPA","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.47,"price_display":"1.47","price_state":"stated","total_value":7350.0,"total_display":"7,350.00","total_whole":"7,350","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-07-28","filed_date":"2008-08-06","scope":"insider"},{"id":1695051,"accession":"0001125282-05-000496","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001125282-05-000496","line_url":"/filing/0001125282-05-000496#line-7","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":168000.0,"total_display":"168,000.00","total_whole":"168,000","shares_owned_after":33578.0,"shares_owned_after_display":"33,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-07","filed_date":"2005-02-07","scope":"insider"},{"id":1695049,"accession":"0001125282-05-000496","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001125282-05-000496","line_url":"/filing/0001125282-05-000496","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18000.0,"shares_display":"18,000","price_per_share":21.13,"price_display":"21.13","price_state":"stated","total_value":380340.0,"total_display":"380,340.00","total_whole":"380,340","shares_owned_after":33578.0,"shares_owned_after_display":"33,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-04","filed_date":"2005-02-07","scope":"insider","n_lines":4},{"id":1214029,"accession":"0001125282-05-000448","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001125282-05-000448","line_url":"/filing/0001125282-05-000448","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":20.509090909090908,"price_display":"20.51","price_state":"stated","total_value":225600.0,"total_display":"225,600.00","total_whole":"225,600","shares_owned_after":34578.0,"shares_owned_after_display":"34,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-02","filed_date":"2005-02-03","scope":"insider","n_lines":2},{"id":1214026,"accession":"0001125282-05-000448","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001125282-05-000448","line_url":"/filing/0001125282-05-000448","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":20.133333333333333,"price_display":"20.13","price_state":"stated","total_value":120800.0,"total_display":"120,800.00","total_whole":"120,800","shares_owned_after":35578.0,"shares_owned_after_display":"35,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-02-01","filed_date":"2005-02-03","scope":"insider","n_lines":5},{"id":1535886,"accession":"0001125282-05-000359","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001125282-05-000359","line_url":"/filing/0001125282-05-000359","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23000.0,"shares_display":"23,000","price_per_share":19.92208695652174,"price_display":"19.92","price_state":"stated","total_value":458208.0,"total_display":"458,208.00","total_whole":"458,208","shares_owned_after":18178.0,"shares_owned_after_display":"18,178","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-31","filed_date":"2005-02-01","scope":"insider","n_lines":17},{"id":1297078,"accession":"0001125282-05-000253","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001125282-05-000253","line_url":"/filing/0001125282-05-000253#line-10","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":38000.0,"total_display":"38,000.00","total_whole":"38,000","shares_owned_after":17778.0,"shares_owned_after_display":"17,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-25","filed_date":"2005-01-25","scope":"insider"},{"id":1297076,"accession":"0001125282-05-000253","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001125282-05-000253","line_url":"/filing/0001125282-05-000253#line-8","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.02,"price_display":"19.02","price_state":"stated","total_value":38040.0,"total_display":"38,040.00","total_whole":"38,040","shares_owned_after":17778.0,"shares_owned_after_display":"17,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-24","filed_date":"2005-01-25","scope":"insider"},{"id":1297074,"accession":"0001125282-05-000253","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001125282-05-000253","line_url":"/filing/0001125282-05-000253","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock (par value $0.0013)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":19.227777777777778,"price_display":"19.23","price_state":"stated","total_value":173050.0,"total_display":"173,050.00","total_whole":"173,050","shares_owned_after":23778.0,"shares_owned_after_display":"23,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-21","filed_date":"2005-01-25","scope":"insider","n_lines":5},{"id":385981,"accession":"0001125282-04-002100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125282-04-002100","line_url":"/filing/0001125282-04-002100","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":19.375,"price_display":"19.38","price_state":"stated","total_value":38750.0,"total_display":"38,750.00","total_whole":"38,750","shares_owned_after":16634.0,"shares_owned_after_display":"16,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-07","filed_date":"2004-05-11","scope":"insider","n_lines":2},{"id":524890,"accession":"0001125282-04-002034","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001125282-04-002034","line_url":"/filing/0001125282-04-002034","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.575,"price_display":"19.58","price_state":"stated","total_value":58725.0,"total_display":"58,725.00","total_whole":"58,725","shares_owned_after":16634.0,"shares_owned_after_display":"16,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-06","filed_date":"2004-05-07","scope":"insider","n_lines":3},{"id":524885,"accession":"0001125282-04-002034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001125282-04-002034","line_url":"/filing/0001125282-04-002034","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":19.525,"price_display":"19.52","price_state":"stated","total_value":78100.0,"total_display":"78,100.00","total_whole":"78,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-05","filed_date":"2004-05-07","scope":"insider","n_lines":3},{"id":300694,"accession":"0001125282-04-001946","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001125282-04-001946","line_url":"/filing/0001125282-04-001946#line-10","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":19.65,"price_display":"19.65","price_state":"stated","total_value":19650.0,"total_display":"19,650.00","total_whole":"19,650","shares_owned_after":16634.0,"shares_owned_after_display":"16,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-04","filed_date":"2004-05-05","scope":"insider"},{"id":300693,"accession":"0001125282-04-001946","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001125282-04-001946","line_url":"/filing/0001125282-04-001946#line-9","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":19550.0,"total_display":"19,550.00","total_whole":"19,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-04","filed_date":"2004-05-05","scope":"insider"},{"id":300692,"accession":"0001125282-04-001946","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001125282-04-001946","line_url":"/filing/0001125282-04-001946#line-8","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250320","owner_name":"PRENTKI RONALD J","owner_display_name":"PRENTKI RONALD J","owner_url":"/insider/0001250320","role":"Director, Officer (President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":19.45,"price_display":"19.45","price_state":"stated","total_value":19450.0,"total_display":"19,450.00","total_whole":"19,450","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-04","filed_date":"2004-05-05","scope":"insider"}],"collapsed":true,"next_cursor":"2004-05-04|300692","ledger_fault":false,"count":{"value":78,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":75,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":78},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"AP PHARMA INC /DE/","url":"/issuer/0000818033","role":"Director, Officer (President & CEO)","n_filings":1,"first_seen":"2008-08-06","last_seen":"2008-08-06"},{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Director, Officer (President)","n_filings":10,"first_seen":"2004-04-21","last_seen":"2005-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250320","retrieved_at":"2026-08-22T08:48:33+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}